See more : Avenue Therapeutics, Inc. (ATXI) Income Statement Analysis – Financial Results
Complete financial analysis of Harbin Xinguang Optic-Electronics Technology Co.,Ltd. (688011.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Harbin Xinguang Optic-Electronics Technology Co.,Ltd., a leading company in the Hardware, Equipment & Parts industry within the Technology sector.
- Press Kogyo Co., Ltd. (7246.T) Income Statement Analysis – Financial Results
- Oxus Acquisition Corp. (OXUSU) Income Statement Analysis – Financial Results
- San Leon Energy plc (SLE.L) Income Statement Analysis – Financial Results
- Summit Bank Group, Inc. (SBKO) Income Statement Analysis – Financial Results
- Addex Therapeutics Ltd (ADXN.SW) Income Statement Analysis – Financial Results
Harbin Xinguang Optic-Electronics Technology Co.,Ltd. (688011.SS)
About Harbin Xinguang Optic-Electronics Technology Co.,Ltd.
Harbin Xinguang Optic-Electronics Technology Co.,Ltd. engages in the research and development, manufacture, and sale of opto-mechanical and electrical integration products, industrial automation control system devices, and optical instruments and optical materials. It also provides technical consulting and other services. The company was founded in 2007 and is headquartered in Harbin, China.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|---|
Revenue | 162.23M | 149.87M | 143.80M | 124.09M | 191.65M | 208.41M | 182.05M | 158.57M |
Cost of Revenue | 105.17M | 110.71M | 75.19M | 74.61M | 76.60M | 107.14M | 63.19M | 43.99M |
Gross Profit | 57.06M | 39.16M | 68.62M | 49.47M | 115.05M | 101.27M | 118.86M | 114.57M |
Gross Profit Ratio | 35.17% | 26.13% | 47.72% | 39.87% | 60.03% | 48.59% | 65.29% | 72.25% |
Research & Development | 42.04M | 35.82M | 33.82M | 21.93M | 25.60M | 12.25M | 9.03M | 12.96M |
General & Administrative | 15.01M | 14.21M | 12.71M | 12.45M | 12.44M | 9.27M | 58.54M | 23.11M |
Selling & Marketing | 21.26M | 18.71M | 16.92M | 10.73M | 8.09M | 4.63M | 3.86M | 2.88M |
SG&A | 36.27M | 32.91M | 29.63M | 23.18M | 20.53M | 13.90M | 62.40M | 25.99M |
Other Expenses | 24.17M | 18.37M | 13.28M | -7.18M | 16.68M | -30.69K | -28.64K | 13.50K |
Operating Expenses | 102.48M | 87.10M | 76.72M | 37.92M | 62.81M | 9.36M | 65.81M | 37.46M |
Cost & Expenses | 207.66M | 197.81M | 151.91M | 112.54M | 139.41M | 116.50M | 129.00M | 81.45M |
Interest Income | 7.67M | 9.49M | 11.07M | 3.63M | 1.58M | 7.51M | 11.31M | 9.29M |
Interest Expense | 157.43K | 163.34K | 290.21K | 190.84K | 2.55M | 5.69M | 4.51M | 5.49M |
Depreciation & Amortization | 19.22M | 15.32M | 16.43M | 15.16M | 14.12M | 9.46M | 5.91M | 2.75M |
EBITDA | -26.06M | -20.25M | 12.00M | 40.79M | 86.99M | 99.94M | 57.97M | 86.55M |
EBITDA Ratio | -16.07% | -9.01% | 19.40% | 37.72% | 44.50% | 51.66% | 37.63% | 56.05% |
Operating Income | -45.43M | -47.94M | 13.83M | 27.63M | 55.80M | 84.30M | 47.06M | 78.13M |
Operating Income Ratio | -28.00% | -31.99% | 9.61% | 22.26% | 29.12% | 40.45% | 25.85% | 49.28% |
Total Other Income/Expenses | -19.69K | 12.13M | -16.19M | 310.94K | 14.49M | -30.69K | -28.64K | 13.50K |
Income Before Tax | -45.45M | -35.81M | -2.36M | 27.94M | 70.29M | 84.27M | 47.03M | 78.15M |
Income Before Tax Ratio | -28.01% | -23.89% | -1.64% | 22.52% | 36.67% | 40.44% | 25.83% | 49.28% |
Income Tax Expense | -4.76M | -9.30M | -3.28M | 3.39M | 9.79M | 11.63M | 6.83M | 11.31M |
Net Income | -39.17M | -26.50M | 924.21K | 24.19M | 60.49M | 72.68M | 40.20M | 66.84M |
Net Income Ratio | -24.14% | -17.68% | 0.64% | 19.50% | 31.57% | 34.87% | 22.08% | 42.15% |
EPS | -0.39 | -0.27 | 0.01 | 0.24 | 0.60 | 0.97 | 0.54 | 0.89 |
EPS Diluted | -0.39 | -0.27 | 0.01 | 0.24 | 0.60 | 0.97 | 0.54 | 0.89 |
Weighted Avg Shares Out | 99.92M | 99.89M | 100.00M | 100.00M | 100.00M | 75.00M | 74.44M | 75.10M |
Weighted Avg Shares Out (Dil) | 99.92M | 99.89M | 100.00M | 100.00M | 100.00M | 75.00M | 74.44M | 75.10M |
Source: https://incomestatements.info
Category: Stock Reports